According to the Absolute Markets Insights’ (AMI) newly published report, the global hospital acquired infection control market was valued at US$ 23.24 Bn in 2020 and is anticipated to witness a compound annual growth rate of 4% over the forecast period (2021 – 2029). The growing incidence of infections across healthcare facilities, increasing awareness towards hygiene along with rising investments towards upgrade of healthcare infrastructure is estimated to contribute towards the market growth over the period of next eight years.

Hospital acquired infection (HAI) or nosocomial infection is defined as an infection that progresses due to impurities in a hospital environment. Such infection is acquired by a patient during a hospital visit. Nosocomial infection is said to be causing significant morbidity as well as mortality in patients. In the era of coronavirus pandemic, this is more visible than ever. Hence, managing and controlling HAI has gained tremendous importance across healthcare facilities at large. Hospitals and other healthcare associated institutions are implementing infection management policies, along with adopting suitable hygiene measures so that hospitals and patient areas can be kept clean. According to the National Surveillance Center (NRZ) of Germany, around 400,000 to 600,000 patients fall ill in Germany due to HAI. Furthermore, in September 2021, a study was published in Infection Control & Hospital Epidemiology highlighted that although hospitals were making serious efforts to prevent the spread of coronavirus through HAI, the rates of other HAI were increasing in the United States of America (USA).

Click Here For More Information: https://www.industryglobalnews24.com/global-hospital-acquired-infection-control-market-was-valued-at-us-2324-bn-in-2020-

Some key players in the global hospital acquired infection control market are 3M, ASP, BELIMED INC., ContecClean, Drägerwerk AG & Co. KGaA, Ecolab Inc., Getinge AB, Keystone Healthcare, MATACHANA GROUP, MELAG Medizintechnik GmbH & Co. KG, Sterigenics U.S. LLC, and STERIS amongst other market participants.

Increasing number of surgical procedures is a big factor contributing towards the growth of global hospital acquired infection control market. In 2019, the World Health Organization (WHO) presented statistics indicating that about 235 million major surgical procedures were performed worldwide every year. The need for these procedures included various ailments that were caused due to growing prevalence of obesity and other lifestyle diseases. Other factors causing high number of people requiring surgeries included the increasing incidence of spinal injuries, rising geriatric population, and sports-related injuries. The growing number of surgical procedures performed results in the increasing demand for different surgical equipment and medical devices. This is expected to proliferate the growth of global hospital acquired infection control market over the future years. Ever since COVID-19 has originated from China, governments and private companies all over the world are implementing measures to prevent the infection, especially HAI. The U.S. Food & Drug Administration (FDA) has recommended that Sterigenics should reopen its ethylene oxide-based sterilization plant in the USA. In March 2020, Sterigenics received permission to reopen the plant for 21 days to sterilize personal protective equipment (PPE) that would be used by healthcare workers during the COVID-19 pandemic. This, along with similar other developments in other countries, is anticipated to drive the global hospital acquired infection control market growth.

Infection control interventions have been implemented in many countries to reduce transmission of coronavirus, which include early identification as well as isolation of patients with minor or severe symptoms, universal source control, the use of appropriate PPE when caring for patients with COVID-19, and implementing all measures for environmental disinfection. According to the data published in American Journal of Infection Control (AJIC, 2020), many people got infected from COVID-19 while visiting hospitals. A substantial number of people suffered from catheter associated urinary tract infections (CAUTI) and central line associated blood stream infections (CLABSI) in this tenure. The incidences have encouraged hospitals to adopt adequate cleaning and sterilizing procedures to prevent COVID-19 spread through HAI, thereby contributing to the growth of hospital acquired infection control market.

Global Hospital Acquired Infection Control Market:

By Offering:
Equipment
Sterilization & Monitoring
Steam Sterilizers
Low Temperature Sterilizers
Ethylene Oxide (EO) Sterilizers
Biological Indicators
Others
Washer Disinfectors
Endoscope Reprocessor Systems
Others
Consumables
Personal Protective Equipment (PPE)
Disinfectants
Others
Services
Training & Education
Support Services
Others

By End Users:
Hospitals & Intensive Care Units (ICUs)
Ambulatory Surgical Centers & Diagnostic Centers
Others

By Distribution Channels:
Direct
Indirect

By Region:
North America
U.S.
Canada
Mexico
Rest of North America
Europe
France
The UK
Spain
Germany
Italy
Nordic Countries
Denmark
Finland
Iceland
Sweden
Norway
Benelux Union
Belgium
The Netherlands
Luxembourg
Rest of Europe
Asia Pacific
China
Japan
India
New Zealand
Australia
South Korea
Southeast Asia
Indonesia
Thailand
Malaysia
Singapore
Rest of Southeast Asia
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Egypt
Kuwait
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America

Contact Us:
Company: Absolute Markets Insights
Email id: [email protected]
Phone: +91-740-024-2424
Contact Name: Shreyas Tanna
Website: https://www.absolutemarketsinsights.com